Congratulations to Molecular Pharmaceutics PhD student Prince Minkah (Pulsipher Lab), on receiving the Excellence in Innovation Graduate Student Award at the University of Utah Technology Licensing Office Innovation Awards!
Prince has tackled the issue of therapy resistance in aggressive solid tumors. His research, focusing on developing selenium-functionalized sulfated hyaluronic acid (sHASe) compounds as novel therapeutics for head and neck cancers, marks a significant in-progress innovation in translational cancer research. His discovery has allowed him to move from molecular design to preclinical validation and begin navigating intellectual property processes. Through his research, Prince has showcased his entrepreneurial mindset, resilience and overall excellence as a graduate student.
Prince shared, "This recognition celebrates creativity, persistence, and the drive to transform bold ideas into impactful research. I am deeply grateful to my mentor, Dr. Abby Pulsipher, for fostering an environment where innovation thrives, and to my colleagues, family, and friends for their continued support and encouragement along the way."
Congratulations Prince!